Health Care Deal News- September 24, 2012


Brought to you by

September 24, 2012 Issue:


  1. Recent Health Care M&A Deals 
  2. Spotlight on: Venture Capital
  3. Spotlight on: Pharmaceuticals
  4. Webcast Calendar

Recent Health Care M&A Deals






Complete Genomics

$117.6 million

Thoma Bravo, LLC.

Mediware Information Systems, Inc.

$195 million





 Eurofins Scientific, Inc.

 Pan Labs - Pharmacology Unit






 ACE Limited

 Asuransi Jaya Proteksi

  80% of stock





 Bionomics Limited

 Eclipse Therapeutics

 $9.98 million


SPECIAL OFFER - New Sector M&A Reports: Order Before September 30th and Save $50.
Our team of experts at The Health Care M&A Information Source has been working around the clock to bring you the inside scoop on the latest in the health care M&A market. Our newest M&A reports are loaded with crucial transaction information, current and historic, to help you make smart investment decisions in these health care sectors: Biotechnology; Home Health and Hospice; Hospital; Managed Care; Medical Device; Not-for-Profit Health Care; and Pharmaceutical. Simply enter coupon code 1208-64e1 upon checkout and save $50 instantly!


Spotlight on: Venture Capital
Most of the venture capital raises we see these days involve companies developing new drug therapies to solve the world’s health problems or new devices to fix a broken body part.  Most of the time, it is difficult to understand the science of what is involved, even though we all know what the goal is.  So it is nice when there is a successful company that is growing, profitable, cost-effective, easy to understand, and most importantly, able to raise $45 million to continue its expansion plans........Read more

How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards!


Spotlight on: Pharmaceuticals
The only other billion-dollar deal of the month  (actually announced during the Labor Day weekend, so technically a September deal) involved a Canadian company, Valeant Pharmaceuticals International (NYSE: VRX) going south of the border to buy Arizona-based Medicis Pharmaceutical Corporation (NYSE: MRX) for $2.6 billion.  Medicis specializes in the treatment of dermatological and aesthetic conditions in the U.S and Canada, and on a combined basis, the two companies will have $1.7 billion in dermatology revenues........Read more

Conference Calendar...Click here to see more